{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-034923","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2023-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.124903+00:00","generated_at":"2026-06-09T17:47:46.519998+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BioLife Solutions names Roderick de Greef CEO; prelim Q3 rev $33.3M, FY23 guidance at low end","bullets":["Michael Rice resigns as CEO and Chairman; Roderick de Greef appointed President, CEO, and Chairman effective Oct 19, 2023.","Preliminary Q3 2023 revenue $33.3M: cell processing $13.3M, storage $6.6M, freezers $13.4M.","FY2023 revenue guidance narrowed to low end of $144M-$158M range; expects flat to modest Q4 cell processing growth.","Garrie Richardson, former GM of biostorage and founder of SciSafe, promoted to Chief Revenue Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-034923","json":"https://secwatch.observer/filing/0001628280-23-034923.json","markdown":"https://secwatch.observer/filing/0001628280-23-034923.md","text":"https://secwatch.observer/filing/0001628280-23-034923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/blfs-20231019.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T17:47:46.519998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e421870202321736bd769dffee0025c0ca8daaf","claim":"BIOLIFE SOLUTIONS INC reported the quarter ended September 30, 2023 results: revenue $33.3 million. Guidance reaffirmed.","evidence_excerpt":"Q3 Preliminary Unaudited Revenue and Updated FY2023 Guidance The Company is reporting preliminary, unaudited revenue for the third quarter of 2023 of approximately $33.3 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$33.3 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"3b174429db","claim":"Michael Rice resigned as Chief Executive Officer and Chairman at BIOLIFE SOLUTIONS INC.","evidence_excerpt":"On October 19, 2023, Michael Rice, the Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of the Company, resigned his positions as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer and Chairman"}],"fact_type":"executive_change"},{"claim_id":"842c30aae4","claim":"Roderick de Greef was appointed as President and Chief Executive Officer and Chairman at BIOLIFE SOLUTIONS INC.","evidence_excerpt":"On October 19, 2023, the Board appointed Roderick de Greef as the President and Chief Executive Officer of the Company (Principal Executive Officer) and Chairman of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer and Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}